The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
EIGA Doc 229/20
Manual handling is an important issue for the industrial gases sector (including all areas such as medical, food etc.). Many activiti...
IX Adeguamento al Progresso Tecnico e scientifico (ATP) Regolamento (CE) 1272/2008 CLP
Regolamento (UE) 2016/1179 della Commissione del 19 luglio 2016 recante modifica, ai fin...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
